期刊文献+

急性缺血性脑卒中的重组组织型纤溶酶原激活剂静脉溶栓治疗与护理 被引量:6

Intravenous treatment of acute ischemic stroke with recombinant tissue-type plasminogen activator and relevant nursing care
下载PDF
导出
摘要 目的探讨急性缺血性脑卒中的静脉溶栓治疗及护理措施。方法对39例发病在6h以内的急性缺血性脑卒中患者(A组),男27例,女12例,年龄50~75岁,静脉注射重组组织型纤溶酶原激活剂(rt-PA)8mg,随后60min内持续静脉泵入rt-PA42mg。溶栓后12h开始皮下注射依诺肝素,连续应用7d。溶栓前中后给予相应的护理监测和措施。非溶栓组(B组)39例,不用溶栓剂及依诺肝素(使用川芎嗪160mg静脉滴注,连续应用7d,其余治疗同溶栓组)。结果rt-PA溶栓治疗后39例溶栓患者的神经功能缺损和患肢肌力均获得不同程度的改善,总显效率达79.4%,无护理并发症发生。结论对发病6h以内的急性缺血性脑卒中患者应用rt-PA溶栓治疗,可降低患者神经功能缺损,最大限度地恢复脑的正常功能,效果满意安全。 Objective To investigate the effects of intravenous thrombolytic treatment of acute ischemic stroke with recombinant tissue-type plasminogen activator (rt-PA) and necessary nursing care measures. Methods 39 patients of acute ischemic stroke with the onset within 6 h, 27 males and 12 females, aged 50-75, received intravenous injection of rt-PA 8 mg, and then continuous intravenous infusion of rt-PA 42 mg. 12 h after the thrombosis enoxaparin was injected subcutaneously for 7 d. Nursing care measures and monitoring were carried out before, during, and after the thrombolytic procedures. Another 39 patients of acute ischemic stroke with the onset within 6 h received the routine treatment (Intravenous infusion of ligustrazine 160 mg for 7 d. )without rt-PA and enoxaparin. Resu Its The clinical manifestations of neurological deficit and decreased muscle strength recovered to different extents. The recanalization rate of thrombosed vessels was 79.4%. No nursing complications occurred. Cone I us i on Efficient and safe for acute ischemic stroke within 6 h after the onset, rt-PA thrombolysis can restore the defective nerve functions.
出处 《中国急救复苏与灾害医学杂志》 2008年第6期359-361,共3页 China Journal of Emergency Resuscitation and Disaster Medicine
基金 北京市科学技术委员会科研基金资助项目(2001541)
关键词 急性缺血性脑卒中 重组组织型纤溶酶原激活剂 护理 Acute ischemic stroke Recombinant tissue-type plasminogen activator Nursing care
  • 相关文献

参考文献8

二级参考文献20

  • 1ResearchGroupofNationalProject85-915-02-01(Correspondence:FuWaiHospi-tal,CAMS&PUMC,Beijing100037).急性心肌梗塞尿激酶临床应用研究(1138例)[J].中华心血管病杂志,1996,24(3):169-173. 被引量:156
  • 2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15767
  • 3徐小林.急性闭塞性脑血管病动脉内溶栓治疗及药物选择[J].国外医学(临床放射学分册),1996,19(5):264-267. 被引量:12
  • 4The collaborative study group for national multicenter clinical trial of urokinase thrombolytic therapy (Correspondence: Hu Dayi, Xu Zhimin. Beijing Red Cross Chao Yao Hospital, Beijing 100020).尿激酶治疗急性心肌梗塞多中心临床试验1406例总结[J].中华心血管病杂志,1997,25(3):176-179. 被引量:138
  • 5TheNationalInstituteofNeurologicalDisordersandStrokertPAStrokeStudyGroup.Tissueplasminogenactivatorforacuteischemicstroke[].NEngJMed.1995
  • 6MulticenterAcuteStrokeTrialItaly(MAST I)Group.Randomisedcontrolledtrialofstreptokinase,aspirinandcombinationofbothintreatmentofacuteischemicstroke[].The Lancet.1995
  • 7Hacke W,Bluhmki E,Steiner T,et al.Dichotomized efficacy end points and global end-point analysis applied to the ECASS in tention-totreat data set.Post hoc analysis of ECASS Ⅰ[].Stroke.1998
  • 8Memezawa H,Simith ML,Siesjo BK.Penumbral tissue salvaged byreperfusion following middle cerebral artery occlusion in rats[].Stroke.1992
  • 9Overgarrd K,Sereghy T,Boysell G,et al.Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model[].Scandinavian Journal of Clinical and Laboratory Investigation.1993
  • 10Del Zoppo GJ,Pessin MS,Mori E,et al.Thrombolytic intervention in acute thrombolic and embolic stroke[].Seminars in Neurology.1991

共引文献427

同被引文献64

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部